Semiautomated Regional Citrate Anticoagulation for Continuous Kidney Replacement Therapy: An Observational Study in Young Children
- PMID: 35583226
- DOI: 10.1097/PCC.0000000000002993
Semiautomated Regional Citrate Anticoagulation for Continuous Kidney Replacement Therapy: An Observational Study in Young Children
Abstract
Objectives: To review use of semiautomated regional citrate anticoagulation (saRCA) for continuous kidney replacement therapy (CKRT) in young children.
Design: Retrospective cohort study.
Setting: Three independent PICUs.
Patients: All consecutive children weighing less than 11 kg who received CKRT with saRCA from January 2015 to June 2020.
Interventions: None.
Measurements and main results: Twenty-one children weighing less than 11 kg underwent CKRT with saRCA. The total duration of the CKRT was 2,014 hours, with a total of 64 CKRT sessions. Citrate intoxication occurred in four of 64 CKRT sessions (6%). Citrate intoxication was consistently observed in the few CKRT sessions where the initial lactate concentration was greater than 4 mmol/L or the ratio of replacement fluid flow to citrate flow less than 50%. The rate of unscheduled interruptions of CKRT sessions was 25% (16/64).
Conclusions: We have used saRCA for CKRT in children weighing less than 11 kg. A strict protocol and intensive training are required to minimize complications.
Copyright © 2022 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
Conflict of interest statement
The authors have disclosed that they do not have any potential conflicts of interest.
References
-
- Davis TK, Neumayr T, Geile K, et al.: Citrate anticoagulation during continuous renal replacement therapy in pediatric critical care. Pediatr Crit Care Med 2014; 15:471–485
-
- Monchi M, Berghmans D, Ledoux D, et al.: Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: A prospective randomized study. Intensive Care Med 2004; 30:260–265
-
- Kutsogiannis DJ, Gibney RT, Stollery D, et al.: Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int 2005; 67:2361–2367
-
- Raymakers-Janssen PAMA, Lilien M, van Kessel IA, et al.: Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children. Pediatr Nephrol 2017; 32:1971–1978
-
- Stucker F, Ponte B, Tataw J, et al.: Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: A randomized controlled trial. Crit Care 2015; 19:91
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
